Janus kinase inhibitors (JAKi) have attracted attention for their role in treating inflammatory disorders. This new class of biologics has the potential to significantly impact the field of dermatology, especially with the development of topical formulations.
https://ift.tt/2qCVhHO
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου